(Nasdaq:PTX) Pernix Therapeutics Holdings Inc Ends Up After Bouncy 94.69% Swing

0
8
PTX
PTX

Pernix Therapeutics Holdings Inc (Nasdaq:PTX)

February 13th, 2019
With markets going up Pernix Therapeutics Holdings Inc closed Wednesday up 52.94%, a $0.63 increase to close on $1.82. Pernix Therapeutics Holdings Inc bounced 94.69% between high and low. The stock continues to trade well at 574.07% of its 52 week low of $0.27. In addition to finishing higher, trading volumes were solid at 3,710.00% of normal which can indicate investors see opportunities. Be aware that the Altman Z-Score1 (An indicator of the probability for a 2-year bankruptcy) is below the recommended threshold of 1.8%, and calculated to be -2.55.

Market Sectors

The market sectors were mixed Wednesday with a majority of the sectors trending up. Energy saw the biggest increase of the day (1.29%), while Utilities saw the biggest drop (-0.31%). Industrials has seen the biggest year-to-date gain at 15.68%.

Energy saw the biggest turnaround from its 5-day performance of -1.99%, as it went up 1.29%. Utilities saw a turn around from its 5-day performance of 1.76% trading down -0.31%.

Sector Breakdown

  • Energy went up with a 1.29% change.
  • Industrials went up with a 0.63% change.
  • Consumer Discretionary went up with a 0.62% change.
  • Real Estate went up with a 0.58% change.
  • Consumer Staples went up with a 0.25% change.
  • Healthcare went up with a 0.25% change.
  • Financials went up with a 0.20% change.
  • Information Technology went up with a 0.14% change.
  • Materials went up with a 0.10% change.
  • Communication Services went down with a -0.10% change.
  • Utilities went down with a -0.31% change.

Pernix Therapeutics Holdings Inc Info

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company’s products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.

All amounts in USD unless otherwise indicated

(1) The Altman Z-Score calculation was first published in 1968 by Edward I. Altman, and is used for predicting the probability that a firm will go into bankruptcy within two years. An Altman Z-Score below 1.8 (Remember that Pernix Therapeutics Holdings Inc’s score is -2.55) is the trigger to be alert for this situation. Some analysts believe this score is less relevant for some companies, in particular companies operating to accumulate users that may run at huge losses to scale up.

PTX daily update

PTX daily update



Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.

This site uses Akismet to reduce spam. Learn how your comment data is processed.